Select your language

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

 2 2014

"Biotechnologia Acta" v. 7, no 2, 2014
https://doi.org/10.15407/biotech7.02.079
Р. 79-85, Bibliography 14, Russian.
Universal Decimal classification:  547.953:615.012:665:372

INFLUENCE OF BIOPREPARATIONS FROM DRY SOYBEAN AND SUNFLOWER LECITHINS ON SERUM LIPIDS COMPOSITION

H. V. Dziak 1, S. M. Shulga 2, M. Adab 3, O. L. Drozdov 3, I. S. Glukh 2

1 State organization «Dniproperovska Medical Acedemy» of  Ministry of Health of Ukraine, Dnipropetrovsk
2 State organization «Institute of Food Biotechnology and Genomics» of National Academy of Sciences of Ukraine, Kyiv
3 Research Institute of Biomedical Problems of State organization «Dnipropetrovsk Medical Academy» of Ministry of Health of Ukraine, Dnipropetrovsk

Dry lecithin, which is a mixture of polar phospholipids, neutral lipids, free fatty acids, glycolipids, carbohydrates, and small amounts of moisture, is a promising object for biologic-hepatoprotectors creation. One of its pharmacological activity displays is its influence on serum lipids, in particular transport forms of these lipids. The influence of dry soy lecithin and sunflower on hyperlipoproteinemia ratio and other lipid disorders is studied.

It is shown that low-fat dry soybean lecithin showed hypocholesterolemic activity against all studied forms of serum cholesterol. Nonfat dry sunflower lecithin had similar but somewhat less prominent effect.

However reduced concentration of high density lipoprotein cholesterol under sunflower lecithin developed right before soya lecithin. Both lecithin prevented the development of dyslipidemia induced carbon tetrachloride.

Key words: soybean and sunflower lecithin biopreparations, serum lipids.

© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2014

References

1.  Drozdov A. L., Shulga S. M., Adab М.,  Glukh I. S. Hepatotropic action of complex biological products of natural origin — sunflower and soy lecithin. Biotechnologia Acta. 2014, 7(1), 123–130. (In Russian).

2.  Drozdov A. L., Postolov О. М., Kudelya І. V. Methods for determination of lipoprotein. DМА, Metodichna rozrobka. Dnipropetrovsk. 2005, 21 p. (In Ukrainian).

3.  Drozdov A. L., Kudelya І. V., Kitenko N. V. Clinical diagnosis and prediction significance for determining lypoproteyn. DМА. Metodicheskoe posobiye. Dnіpropetrovsk. 2007, 24 p. (In Russian).

4. Dzyak G. V., Drozdov A. L., Shulga S. M.,  Glukh A. I., Glukh I. S. Modern presentation of biology properties of lecithin. Medychni perspektyvy. 2010, ХV(2), P. 12–23. (In Russian).

5. Shulga S. M., Glukh I. S., Drozdov О. L. Biological properties of sunflower lecithin. ONAFT, Naukovi pratsi. 2012, V. 1, Issue 42, P. 234–238. (In Ukrainian).

6.  LeBlanc M. J., Brunet S., Bouchard G. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats. J. Nutr. Biochem. 2003, 14(1), 40–48.
https://doi.org/10.1016/S0955-2863(02)00253-X

7.  Knuiman J. T., Beunen A. C., Katan M. B. Lecithin intake and serum cholesterol. Am. J. Clin. Nutr. 1989, V. 49, P. 266–268.

8.  Mourad A. M., Pincinato E. C., Mazzola P. G. Sabha M., Moriel P. Influence of soy lecithin administration on Hypercholesterplemia. Cholesterol. V. 2010. Article ID 824814. P. 1–4.

9.  Maligan J. M., Estiasih T., Kusnadi J. Structured phospholipids from commercial soybean lecithin containing omega-3 fatty acids reduces atherosclerosis risk in male Sprague dawley rats which fed with an atherogenic diet. World Academy of Science, Engineering and Technology. 2012, V. 69, P. 502–508.

10.  European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Council of Europe, Strasbourg, 1986, 53 p.

11.  Мenshikov V. V., Delektorskay Л. N., Zolotnitskay R. P., Andreeva Z. М., Ankirskay А. S. Laboratory methods in clinical studies: Handbook. Ed. V. V. Menshikov. Мoscow: Medicine. 1987, 368 p. (In Russian).

12.  Dzyak G. V., Drozdov A. L., Bilozub V. V., Kudelya І. V., Kharaponova О. B. Method for determining fractions of lipoprotein. Patent for utility model 60647. Patent was published 25.06.2011, Bul. 12/2011. (In Ukrainian).

13.  Tvorogova М. G. Laboratory diagnosis of lipid disorders. Laboratory medicine. 2001, N 4, P. 67–74. (In Russian).

14.  Plokhinskiy N. A. Biometrics. М.: Izd-vо Moskovskogo un-tа. 1978, 368 p. (In Russian).